In addition, when SLP2 is used as a model antigen in MM, the patient’s paraprotein binds to both the wild type SLP2 and the actually immunogenic post-translationally hyper-phosphorylated variant of SLP2. Here, STOML2 is linked to Miyoshi myopathy.